IP Library › Assignment 061613/0897
Patent Assignment
Reel/Frame 061613/0897

Merger and Change of Name

Recorded: 2022-09-27 Pages: 77
Assignors
SEATTLE CANCER CARE ALLIANCE
Executed: 2022-03-30
Assignee
FRED HUTCHINSON CANCER CENTER
1100 FAIRVIEW AVENUE N, SEATTLE, WASHINGTON, 98109
Covered Properties (4)
Enhanced Generation of Cytotoxic T-Lymphocytes by Il-21 Mediated FOXP3 Suppression
Patent: 9,809,797 →
Application: 12/677,035 →
Publication: US 2010/0330056
Enhanced Generation of Cytotoxic T Lymphocytes by Il-21 Mediated FOXP3 Suppression
Application: 15/188,096 →
Publication: US 2016/0298081
Enhanced Generation of Cytotoxic T-Lymphocytes by Il-21 Mediated FOXP3 Suppression
Application: 16/100,113 →
Publication: US 2019/0024050
Enhanced Generation of Cytotoxic T-Lymphocytes by Il-21 Mediated FOXP3 Suppression
Application: 17/400,038 →
Publication: US 2022/0073879
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 8, 2010
From: YEE, CASSIAN; LI, YONGQING
To: THE FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 024206/0698 →
Confirmatory License Jan 12, 2017
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041346/0263 →
Assignment of Assignor's Interest Aug 8, 2018
From: YEE, CASSIAN; LI, YONGQING
To: THE FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 046584/0769 →
Assignment of Assignor's Interest Aug 9, 2018
From: YEE, CASSIAN; LI, YONGQING
To: THE FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 046608/0983 →
Confirmatory License Aug 9, 2018
From: THE FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046762/0849 →
Assignment of Assignor's Interest Nov 12, 2021
From: YEE, CASSIAN; LI, YONGQING
To: THE FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 058098/0967 →